BPC 157: Miracle Healing Peptide or Hidden Danger? The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Sends Warning Letters to More Than 50 GLP 1 Compounders and Manufacturers Wilson Sonsini FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions